[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.146.179.146. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
October 1983

Initial Anticholinergic Prophylaxis for Neuroleptic-Induced Extrapyramidal Syndromes

Author Affiliations

From the Departments of Psychiatry (Drs Keepers, Clappison, and Casey) and Neurology (Dr Casey), School of Medicine, Oregon Health Sciences University, and Medical Research, Psychiatry, and Neurology Services (Dr Casey), Veterans Administration Medical Center, Portland.

Arch Gen Psychiatry. 1983;40(10):1113-1117. doi:10.1001/archpsyc.1983.01790090075012
Abstract

• Initial prophylaxis with anticholinergics for neurolepticinduced extrapyramidal syndromes (EPSs) is controversial. Recommendations, based on conflicting research findings, vary from routine prophylactic use of anticholinergics to withholding these agents until dystonia, akathisia, or parkinsonism develops. To determine whether anticholinergic prophylaxis influenced EPS rates during the first 21 days of neuroleptic treatment, 215 psychotic inpatients were reviewed. Initial prophylaxis with anticholinergic drugs significantly reduced the occurrence of EPSs. This treatment's efficacy depended on a complex interaction of variables, including the patient's sex and age, antipsychotic drug type and dose, and treatment phase.

×